O4.08 AGI5198, AN INHIBITOR OF IDH1R132H, PROTECTS IDH1R132H HCT116 CELLS AGAINST IRRADIATION
BACKGROUND: IDH1R132H mutations are both inaugural events in the formation of glioma and associated with prolonged glioma patient survival. The IDH1R132H mutation confers a neo-enzymatic function that results in accumulation of the oncometabolite D-2-hydroxyglutarate (D-2HG), which promotes gliomage...
Saved in:
Published in | Neuro-oncology (Charlottesville, Va.) Vol. 16; no. suppl 2; pp. ii8 - ii9 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
01.09.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!